These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2746835)

  • 1. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies.
    Chávez GF; Mulinare J; Cordero JF
    JAMA; 1989 Aug; 262(6):795-8. PubMed ID: 2746835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urogenital anomalies in the offspring of women using cocaine during early pregnancy--Atlanta, 1968-1980.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Aug; 38(31):536, 541-2. PubMed ID: 2502709
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genitourinary tract malformations and maternal cocaine abuse.
    Greenfield SP; Rutigliano E; Steinhardt G; Elder JS
    Urology; 1991 May; 37(5):455-9. PubMed ID: 2024395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study.
    Given JE; Loane M; Garne E; Addor MC; Bakker M; Bertaut-Nativel B; Gatt M; Klungsoyr K; Lelong N; Morgan M; Neville AJ; Pierini A; Rissmann A; Dolk H
    BMJ; 2018 Jun; 361():k2477. PubMed ID: 29941493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal cocaine abuse and fetal anomalies: evidence for teratogenic effects of cocaine.
    Hannig VL; Phillips JA
    South Med J; 1991 Apr; 84(4):498-9. PubMed ID: 2014437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of oral contraceptives in pregnancy and major structural birth defects in offspring.
    Waller DK; Gallaway MS; Taylor LG; Ramadhani TA; Canfield MA; Scheuerle A; Hernández-Diaz S; Louik C; Correa A;
    Epidemiology; 2010 Mar; 21(2):232-9. PubMed ID: 20087193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal thyroid disease and risk of birth defects in offspring: a population-based case-control study.
    Khoury MJ; Becerra JE; d'Almada PJ
    Paediatr Perinat Epidemiol; 1989 Oct; 3(4):402-20. PubMed ID: 2479928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester anesthesia exposure and the risk of central nervous system defects: a population-based case-control study.
    Sylvester GC; Khoury MJ; Lu X; Erickson JD
    Am J Public Health; 1994 Nov; 84(11):1757-60. PubMed ID: 7977913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal periconceptional illicit drug use and the risk of congenital malformations.
    van Gelder MM; Reefhuis J; Caton AR; Werler MM; Druschel CM; Roeleveld N;
    Epidemiology; 2009 Jan; 20(1):60-6. PubMed ID: 19057385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies.
    Abe K; Honein MA; Moore CA
    Birth Defects Res A Clin Mol Teratol; 2003 Nov; 67(11):911-8. PubMed ID: 14745928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does light-to-moderate alcohol consumption during pregnancy increase the risk for renal anomalies among offspring?
    Moore CA; Khoury MJ; Liu Y
    Pediatrics; 1997 Apr; 99(4):E11. PubMed ID: 9099786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study.
    Bergman JEH; Lutke LR; Gans ROB; Addor MC; Barisic I; Cavero-Carbonell C; Garne E; Gatt M; Klungsoyr K; Lelong N; Lynch C; Mokoroa O; Nelen V; Neville AJ; Pierini A; Randrianaivo H; Rissmann A; Tucker D; Wiesel A; Dolk H; Loane M; Bakker MK
    Drug Saf; 2018 Apr; 41(4):415-427. PubMed ID: 29230691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in rates of multiple vascular disruption defects, Atlanta, 1968-1989: is there evidence of a cocaine teratogenic epidemic?
    Martin ML; Khoury MJ; Cordero JF; Waters GD
    Teratology; 1992 Jun; 45(6):647-53. PubMed ID: 1412057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periconceptional use of multivitamins and the occurrence of neural tube defects.
    Mulinare J; Cordero JF; Erickson JD; Berry RJ
    JAMA; 1988 Dec; 260(21):3141-5. PubMed ID: 3184392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine and single ventricle: a population study.
    Martin ML; Khoury MJ
    Teratology; 1992 Sep; 46(3):267-70. PubMed ID: 1523584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloverleaf skull and multiple congenital anomalies in a girl exposed to cocaine in utero: case report and review of the literature.
    Esmer MC; Rodriguez-Soto G; Carrasco-Daza D; Iracheta ML; Del Castillo V
    Childs Nerv Syst; 2000 Mar; 16(3):176-9; discussion 180. PubMed ID: 10804054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital genitourinary tract abnormalities following cocaine exposure in utero.
    Battin M; Albersheim S; Newman D
    Am J Perinatol; 1995 Nov; 12(6):425-8. PubMed ID: 8579655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of congenital anomalies in pregnant users of statin drugs.
    Ofori B; Rey E; Bérard A
    Br J Clin Pharmacol; 2007 Oct; 64(4):496-509. PubMed ID: 17506782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.